Clinical Trials
3 trialsNCT04543188 2025-10-23
A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement
Pfizer
Phase 1 Terminated
NCT02244112 2021-02-21
A Phase 1 Study of Oprozomib to Assess Food Effect, Drug-Drug Interaction With Midazolam, and Safety and Tolerability in Patients With Advanced Malignancies
Amgen
Phase 1 Terminated
NCT02317341 2019-03-20
Effect of Ketamine on Fatigue Following Cancer Therapy
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Terminated